• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Bullsh*t Sites Confusing XXII Investors with Fake Price Target News

October 17, 2017


Yesterday, Chardan's James McIlree reiterated a 'buy' rating on shares of 22nd Century Group, Inc. (NYSE:XXII) alongside a price target of $11.50 per share. While the term fake news is usually used by President Trump, it's the most fitting term to describe some of the XXII-related articles we've seen floating around today. 


The report called 22nd Century Group "the solution to big tobacco's $30B problem." Chardan's "$11.50 price target is based on the company garnering royalty revenue for its technology on 10% of the US market share in the next five years." Risks to achieving the target price include "delays in the FDA process, ability to find partners for X-22, challenges in attracting contract manufacturing and selling product overseas and possibility of requiring additional capital." 


Fake News


Today, many investors are being confused and mislead by a handful of illegitimate financial news sites publishing articles claiming that Chardan lowered its price target today from $11.50 per share to $3.50 per share. Sites publishing this $3.50 price target today include StockNewsTimes.comTheStreetPoint.com, and more.


We wanted to step in to clear the air. Chardan's price target for 22nd Century Group, Inc. is in fact $11.50 per share. Don't take our word for it though! Below is a screenshot of an e-mail received just 3 hours ago from Kaitlynn Alico, Investor Relations Coordinator for 22nd Century Group, confirming the $11.50 per share price target assigned by Chardan.


The $3.50 price target was actually Chardan's price target for share of XXII back on August 10th, when analyst James McIlree, CFA issued a follow-up report to the company's strong Q2 financial results. 


To read the most recent report from Chardan click here


To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!



Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.